利索-全球专利检索

  1. 登录
  2. 注册
发明公开
CN110172515A CNTN3蛋白在神经胶质瘤预后判断中的应用 审中-实审

CNTN3蛋白在神经胶质瘤预后判断中的应用
摘要：
本发明公开了CNTN3蛋白的用途，CNTN3蛋白在制备用于神经胶质瘤诊断、预后判断药物或治疗药物中的应用；以及编码CNTN3蛋白的mRNA在制备用于神经胶质瘤诊断、预后判断或治疗药物中的应用。本发明通过检测组织样本中的CNTN3蛋白/mRNA，可有效的对胶质瘤患者预后进行判断。本发明可为神经胶质瘤患者的预后分析提供强有力的技术支持，有助于临床医生选择合理的后续治疗方案，提高神经胶质瘤患者的术后生活质量，提高患者生存率，本发明具有深远的临床意义，适合临床推广应用。
摘要（英）：

The invention discloses usages of CNTN3 protein, application of the CNTN3 protein in preparation of drugs for diagnosis and prognosis judgement or treatment of neuroglioma, and application of mRNA encoding the CNTN3 protein in preparation of the drugs for diagnosis and prognosis judgement or treatment of neuroglioma. By detecting the CNTN3 protein/mRNA in a tissue sample, the prognosis of a gliomapatient can be judged effectively. The usages of the CNTN3 protein disclosed by the invention can provide strong technical support for prognosis analysis of a neuroglioma patient, are beneficial fora clinician to choose a reasonable subsequent therapeutic schedule, improve postoperative living quality of the neuroglioma patient, increase survival rate of the patient, have profound clinical significance, and are suitable for clinical popularization and application.

0/0